By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

References

  1. The European Aesthetic Guide Spring 2015
  2. TEOXANE Laboratories. Safety and effectiveness of three new dynamic fillers for the treatment of moderate to severe nasolabial folds: an 18-month randomized controlled trial versus competitors
  3. Berguiga M, Galatoire O. Tear trough rejuvenation: A safety evaluation of thetreatment by a semi-cross-linked hyaluronic acid filler. Orbit. 2017Feb;36(1):22-26
  4. Fanian F, Jeudy A, Lihoreau T et al. In-vivo injection of oligonutrients and high molecular weight hyaluronic acid - results of a randomized controlled trial. In press
  5. Wisniewski JD, Ellis DL, Lupo MP. Facial rejuvenation: combining cosmeceuticals with cosmetic procedures. Cutis. 2014 Sep;94(3):12
  6. TEOXANE Data on File. TEOSYAL RHA® Brochure_500274-04
  7. Gutowski KA. Hyaluronic acid fillers: science and clinical uses. Clin Plast Surg. 2016;43(3):489-96.
  8. Coleman SR, Grover R. The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1S):S4-9.
  9. Pao KY, Mancini R. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers. Curr Opin Ophthalmol. 2014;25(5):461-9.
  10. Michaud T, Gassia V, Belhaouari L. Facial dynamics and emotional expressions in facial aging treatments. J Cosmet Dermatol. 2015;14(1):9-21.
  11. Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol. 2010;55(1):8-14.
  12. TEOXANE DoF 207414-E_ADV-TEOSYAL_UK.pdf (page 56, reference 3: TEOXANE International study 2017)
  13. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2(3):369-76
  14. Bass LS. Injectable filler techniques for facial rejuvenation, volumization, and augmentation. Facial Plast Surg Clin North Am. 2015;23(4):479-88.
  15. Luthra A. Shaping lips with fillers. J Cutan Aesthet Surg. 2015;8(3):139-42.
  16. Emre IE, Cakmak O. Ageing face, an overview – Aetiology, assessment and management. Otorhinolaryngol. 2013;6(3):160-6.
  17. Braz A, Humphrey S, Weinkle S, Yee GJ, et al. Lower face: clinical anatomy and regional approaches with injectable fillers. Plast Reconstr Surg. 2015;136(5 Suppl):235S-57S.
  18. Vanaman M, Fabi SG, Cox SE. Neck rejuvenation using a combination approach: our experience and a review of the literature. Dermatol Surg. 2016;42 Suppl 2:S94-S100.
  19. Pierre S, Liew S, Bernardin A. Basics of dermal filler rheology. Dermatol Surg. 2015;41 Suppl 1:S120-6.
  20. Study Report TEOSYAL® PureSense Redensity [I]. Dr Knoll, Dr Vivier, Dr Carre, Dr Micheels. 2013.
  21. TEOXANE Data on File.Teosyal RHA® 1 Notice.
  22. TEOXANE Data on File.Teosyal RHA® 2 Notice.
  23. TEOXANE Data on File.Teosyal RHA® 3 Notice.
  24. TEOXANE Data on File.Teosyal RHA® 4 Notice.
  25. Post Market Survey (PMS) 2018; RHA range
  26. TEOXANE Data on File. TEOSYAL® PURESENSE REDENSITY 1 Notice
  27. TEOXANE Data on File. TEOSYAL® PURESENSE REDENSITY 2 Notice
  28. TEOXANE Data on File. TEOSYAL® PURESENSE ULTRA DEEP Notice
  29. TEOXANE Data on File. TEOSYAL® ULTRA DEEP Notice
  30. TEOXANE Data on File. TEOSYAL PURESENSE KISS® Notice
  31. TEOXANE Data on File. TEOSYAL KISS® Notice
  32. Smith KC. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations. Dermatol Online J. 2008 Aug 15;14(8):3: Available online at http://escholarship.org/uc/item/25v7q60x
  33. Topical report. Injectible products to fill wrinkles. France: ANSM: Agence nationale de sécurité du médicament et des produits de santé; 2012
  34. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging. 2008;3(1):153-9
  35. Figus A, Wormald JC, Wade RG, Bistoni G. Hyaluronic acid for facial rejuvenation. In: Curinga G, Rusciani A, eds. Minimally Invasive Procedures for Facial Rejuvenation. Foster City, USA: OMICS Group eBooks; 2014
  36. TEOXANE Data on File_Beauty pass_EN_500023/09
  37. Tosti A, De Padova MP. Atlas of Mesotherapy in Skin Rejuvenation. London, UK: Informa Healthcare; 2007
  38. TEOXANE Data on File. Skincare Revolution Brochure_600104-04
    In-vivo test and use test carried out on 16 volunteers during 7 days by an independant laboratory
  39. TEOXANE Data on File_Beauty pass_EN_50002308
  40. Baumann L. Skin ageing and its treatment. J Pathol. 2007;211(2):241-51
  41. Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E, Zouboulis CC. Skin anti-aging strategies. Dermatoendocrinol. 2012;4(3):308-19
  42. Zimbler MS, Kokoska MS, Thomas JR. Anatomy and pathophysiology of facial aging. Facial Plast Surg Clin North Am. 2001 May;9(2):179-87
  43. Olejnik, A., Goscianska, J. and Nowak, I. Significance of hyaluronic acid in cosmetic industry and aesthetic medicine. Chemik 66, 129–135 (2012)
  44. Kenner JR. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy. J Drugs Dermatol. 2010 Sep;9(9):1135-8
  45. Brown MB, Jones SA. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venereol. 2005 May;19(3):308-18.
  46. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012 Jul 1;4(3):253-8.
  47. Mendoza G, Prieto JG, Real R, et al. Antioxidant profile of hyaluronan: physico-chemical features and its role in pathologies. Mini Rev Med Chem. 2009 Nov 1;9(13):1479-88.
  48. Sundaram H, Mackiewicz N, Burton E, et al. Pilot Comparative Study of the Topical Action of a Novel, Crosslinked Resilient Hyaluronic Acid on Skin Hydration and Barrier Function in a Dynamic, Three-Dimensional Human Explant Model. J Drugs Dermatol. 2016 Apr;15(4):434-41.
  49. Data on File. 3
  50. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997 Jul;242(1):27-33.
  51. Robert L, Robert AM, Renard G. Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging. Pathol Biol (Paris). 2010 Jun;58(3):187-98.
  52. Robert L. Hyaluronan, a truly "youthful" polysaccharide. Its medical applications. Pathol Biol (Paris). 2015 Feb;63(1):32-4.
  53. Farage MA, Miller KW, Elsner P, Maibach HI. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol. 2007;26(4):343-57.
  54. Anderegg U, Simon JC, Averbeck M. More than just a filler - the role of hyaluronan for skin homeostasis. Exp Dermatol. 2014 May;23(5):295-303.
  55. Lemperle G, Holmes RE, Cohen SR, Lemperle SM. A classification of facial wrinkles. Plast Reconstr Surg. 2001 Nov;108(6):1735-50
  56. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006 Aug;85(8):699-715.
  57. Stevenson S, Thornton J. Effect of estrogens on skin aging and the potential role of SERMs. Clinical Interventions in Aging. 2007;2(3):283-297.
  58. Dahiya P, Kamal R. Hyaluronic Acid: a boon in periodontal therapy. N Am J Med Sci. 2013 May;5(5):309-15.
  59. R1. Faivre J, et al. Advanced Concepts in Rheology for the Evaluation of Hyaluronic Acid-Based Soft Tissue Fillers. Dermatol Surg. 2021 Jan.
  60. Micheels P, Sarazin D, Besse S, Eliasd B. Comparison of Two Swiss-Designed Hyaluronic Acid Gels: Six-Month Clinical Follow-Up. J Drugs Dermatol. 2017 Feb 1;16(2):154-161.
  61. Teoxane Survey Europe & MENA “Lip treatment in clinics” by 239 injectors, December 2020
  62. RHA KISS® = TEOSYAL RHA KISS® – Instructions for use
  63. RHA® 3 = TEOSYAL RHA® 3 – Instruction for use
  64. After 28 days of use, self-assessment
  65. In-vivo test evalutation carried out on 22 volunteers during 28 days by an independent laboratory, 2019
  66. [3D]Lip is a cosmetic product according to European regulation 1223/2009. Cosmetic products are not designed to be injected.
  67. Cotofana S. et al. Facial Plast Surg. 2016; 32:253-260.
  68. Toledo Avelar LE. et al. Plast Reconstr Surg Glob Open. 2017; 5(4):e1297.
  69. Rorhich and Pessa, Plast Reconstr Surg 2012; 129(1):274–5.
  70. Ramanadham R. & Rohrich R.Plast Reconstr Surg. 2015; 136:49S-55S.
  71. TEOSYAL® PureSense Ultra Deep – instruction for use.
  72. TEOSYAL RHA® 4 – instruction for use.
  73. Data on file. TEOSYAL RHA® keeps its mechanical properties on a large range of strain or stress contraints - Report Rheological characterizations of hyaluronic acid gels.
  74. Rzany B, et al. Dermatol Surg. 2019;45(10):1304-1314.
  75. Data on file. Internal report RDRE 2015 » (Rheological analysis of Volumizers Ultra Deep/RHA4/Lyft /Voluma).
  76. Kaufman-Janette J, et al. J Cosmet Dermatol. 2019;10.1111/jocd.13100.
  77. Sundaram et al. J Drugs Dermatol. 2018; 17(4),442-450.
  78. Data on file. Study report FU.04.C_2013/618. In vivo evaluation of the anti-ageing efficacy of a cosmetic product (in Vivo test performed on 30 volunteers during 28 days by an independent laboratory.) 2013.
NEWSLETTER
Sign up to our newsletter to stay up-to-date with our latest news
Subscribe